메뉴 건너뛰기




Volumn 10, Issue 2, 2014, Pages

Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma

(49)  Borad, Mitesh J a,b   Champion, Mia D a,b   Egan, Jan B b   Liang, Winnie S c   Fonseca, Rafael a,b   Bryce, Alan H a,b   McCullough, Ann E a   Barrett, Michael T a,c   Hunt, Katherine a   Patel, Maitray D a   Young, Scott W a   Collins, Joseph M a   Silva, Alvin C a   Condjella, Rachel M a   Block, Matthew b,d   McWilliams, Robert R b,d   Lazaridis, Konstantinos N b   Klee, Eric W a,b   Bible, Keith C d   Harris, Pamela e   more..


Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; FIBROBLAST GROWTH FACTOR RECEPTOR 2; PAZOPANIB; PONATINIB; TRANSCRIPTOME; EGFR PROTEIN, HUMAN; FGFR2 PROTEIN, HUMAN; IMIDAZOLE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIDAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE; QUINAZOLINE DERIVATIVE; SULFONAMIDE;

EID: 84901742112     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004135     Document Type: Article
Times cited : (297)

References (113)
  • 1
    • 0029973585 scopus 로고    scopus 로고
    • Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea
    • Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, et al. (1996) Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. International journal of epidemiology 25: 933-940.
    • (1996) International Journal of Epidemiology , vol.25 , pp. 933-940
    • Shin, H.R.1    Lee, C.U.2    Park, H.J.3    Seol, S.Y.4    Chung, J.M.5
  • 2
    • 0029779857 scopus 로고    scopus 로고
    • Cholangiocarcinoma in patients with opisthorchiasis
    • Watanapa P, (1996) Cholangiocarcinoma in patients with opisthorchiasis. The British journal of surgery 83: 1062-1064.
    • (1996) The British Journal of Surgery , vol.83 , pp. 1062-1064
    • Watanapa, P.1
  • 5
    • 0031914317 scopus 로고    scopus 로고
    • Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study
    • Bergquist A, Glaumann H, Persson B, Broome U, (1998) Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 27: 311-316.
    • (1998) Hepatology , vol.27 , pp. 311-316
    • Bergquist, A.1    Glaumann, H.2    Persson, B.3    Broome, U.4
  • 10
    • 0034212347 scopus 로고    scopus 로고
    • Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis
    • Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, et al. (2000) Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer 88: 2471-2477.
    • (2000) Cancer , vol.88 , pp. 2471-2477
    • Kobayashi, M.1    Ikeda, K.2    Saitoh, S.3    Suzuki, F.4    Tsubota, A.5
  • 12
    • 15744389434 scopus 로고    scopus 로고
    • Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study
    • Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA, (2005) Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128: 620-626.
    • (2005) Gastroenterology , vol.128 , pp. 620-626
    • Shaib, Y.H.1    El-Serag, H.B.2    Davila, J.A.3    Morgan, R.4    McGlynn, K.A.5
  • 14
    • 4143131235 scopus 로고    scopus 로고
    • Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma
    • Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, et al. (2004) Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer science 95: 592-595.
    • (2004) Cancer Science , vol.95 , pp. 592-595
    • Yamamoto, S.1    Kubo, S.2    Hai, S.3    Uenishi, T.4    Yamamoto, T.5
  • 15
    • 0035683092 scopus 로고    scopus 로고
    • Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy
    • Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, et al. (2001) Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer causes & control: CCC 12: 959-964.
    • (2001) Cancer Causes & Control: CCC , vol.12 , pp. 959-964
    • Donato, F.1    Gelatti, U.2    Tagger, A.3    Favret, M.4    Ribero, M.L.5
  • 16
    • 0036378417 scopus 로고    scopus 로고
    • What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma?
    • Lee CC, Wu CY, Chen GH, (2002) What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma? Journal of gastroenterology and hepatology 17: 1015-1020.
    • (2002) Journal of Gastroenterology and Hepatology , vol.17 , pp. 1015-1020
    • Lee, C.C.1    Wu, C.Y.2    Chen, G.H.3
  • 17
    • 44449131763 scopus 로고    scopus 로고
    • Mortality among Thorotrast-exposed patients and an unexposed comparison group in the German Thorotrast study
    • Becker N, Liebermann D, Wesch H, Van Kaick G, (2008) Mortality among Thorotrast-exposed patients and an unexposed comparison group in the German Thorotrast study. European journal of cancer 44: 1259-1268.
    • (2008) European Journal of Cancer , vol.44 , pp. 1259-1268
    • Becker, N.1    Liebermann, D.2    Wesch, H.3    Van Kaick, G.4
  • 18
    • 0347384242 scopus 로고    scopus 로고
    • Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast
    • Travis LB, Hauptmann M, Gaul LK, Storm HH, Goldman MB, et al. (2003) Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast. Radiation research 160: 691-706.
    • (2003) Radiation Research , vol.160 , pp. 691-706
    • Travis, L.B.1    Hauptmann, M.2    Gaul, L.K.3    Storm, H.H.4    Goldman, M.B.5
  • 21
    • 0027771839 scopus 로고
    • Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand
    • Kiba T, Tsuda H, Pairojkul C, Inoue S, Sugimura T, et al. (1993) Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand. Molecular carcinogenesis 8: 312-318.
    • (1993) Molecular Carcinogenesis , vol.8 , pp. 312-318
    • Kiba, T.1    Tsuda, H.2    Pairojkul, C.3    Inoue, S.4    Sugimura, T.5
  • 26
    • 0025169651 scopus 로고
    • Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing
    • Tada M, Omata M, Ohto M, (1990) Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Cancer research 50: 1121-1124.
    • (1990) Cancer Research , vol.50 , pp. 1121-1124
    • Tada, M.1    Omata, M.2    Ohto, M.3
  • 27
    • 0025264589 scopus 로고
    • [Detection of ras gene mutations of primary hepatic malignant tumors by polymerase chain reaction and direct sequencing method]
    • Tada M, Omata M, Ohto M, (1990) [Detection of ras gene mutations of primary hepatic malignant tumors by polymerase chain reaction and direct sequencing method]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 87: 811-815.
    • (1990) Nihon Shokakibyo Gakkai Zasshi = The Japanese Journal of Gastro-Enterology , vol.87 , pp. 811-815
    • Tada, M.1    Omata, M.2    Ohto, M.3
  • 28
    • 0026547213 scopus 로고
    • High incidence of ras gene mutation in intrahepatic cholangiocarcinoma
    • Tada M, Omata M, Ohto M, (1992) High incidence of ras gene mutation in intrahepatic cholangiocarcinoma. Cancer 69: 1115-1118.
    • (1992) Cancer , vol.69 , pp. 1115-1118
    • Tada, M.1    Omata, M.2    Ohto, M.3
  • 30
    • 0034053517 scopus 로고    scopus 로고
    • Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development
    • Boberg KM, Schrumpf E, Bergquist A, Broome U, Pares A, et al. (2000) Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development. Journal of hepatology 32: 374-380.
    • (2000) Journal of Hepatology , vol.32 , pp. 374-380
    • Boberg, K.M.1    Schrumpf, E.2    Bergquist, A.3    Broome, U.4    Pares, A.5
  • 31
    • 0034050615 scopus 로고    scopus 로고
    • Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver
    • Tannapfel A, Weinans L, Geissler F, Schutz A, Katalinic A, et al. (2000) Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver. Digestive diseases and sciences 45: 317-324.
    • (2000) Digestive Diseases and Sciences , vol.45 , pp. 317-324
    • Tannapfel, A.1    Weinans, L.2    Geissler, F.3    Schutz, A.4    Katalinic, A.5
  • 35
    • 0033150246 scopus 로고    scopus 로고
    • Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma
    • Ahrendt SA, Eisenberger CF, Yip L, Rashid A, Chow JT, et al. (1999) Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma. The Journal of surgical research 84: 88-93.
    • (1999) The Journal of Surgical Research , vol.84 , pp. 88-93
    • Ahrendt, S.A.1    Eisenberger, C.F.2    Yip, L.3    Rashid, A.4    Chow, J.T.5
  • 37
    • 0036771842 scopus 로고    scopus 로고
    • p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma
    • Taniai M, Higuchi H, Burgart LJ, Gores GJ, (2002) p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma. Gastroenterology 123: 1090-1098.
    • (2002) Gastroenterology , vol.123 , pp. 1090-1098
    • Taniai, M.1    Higuchi, H.2    Burgart, L.J.3    Gores, G.J.4
  • 38
    • 0033756536 scopus 로고    scopus 로고
    • Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver
    • Tannapfel A, Benicke M, Katalinic A, Uhlmann D, Kockerling F, et al. (2000) Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut 47: 721-727.
    • (2000) Gut , vol.47 , pp. 721-727
    • Tannapfel, A.1    Benicke, M.2    Katalinic, A.3    Uhlmann, D.4    Kockerling, F.5
  • 39
    • 0028981089 scopus 로고
    • Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers
    • Yoshida S, Todoroki T, Ichikawa Y, Hanai S, Suzuki H, et al. (1995) Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Cancer research 55: 2756-2760.
    • (1995) Cancer Research , vol.55 , pp. 2756-2760
    • Yoshida, S.1    Todoroki, T.2    Ichikawa, Y.3    Hanai, S.4    Suzuki, H.5
  • 40
    • 84856298658 scopus 로고    scopus 로고
    • Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping
    • Borger DR, Tanabe KK, Fan KC, Lopez HU, Fantin VR, et al. (2012) Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. The oncologist 17: 72-79.
    • (2012) The Oncologist , vol.17 , pp. 72-79
    • Borger, D.R.1    Tanabe, K.K.2    Fan, K.C.3    Lopez, H.U.4    Fantin, V.R.5
  • 42
    • 79251579592 scopus 로고    scopus 로고
    • Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma
    • Gu TL, Deng X, Huang F, Tucker M, Crosby K, et al. (2011) Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PloS one 6: e15640.
    • (2011) PloS One , vol.6
    • Gu, T.L.1    Deng, X.2    Huang, F.3    Tucker, M.4    Crosby, K.5
  • 43
    • 27144523155 scopus 로고    scopus 로고
    • Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas
    • Gwak GY, Yoon JH, Shin CM, Ahn YJ, Chung JK, et al. (2005) Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas. Journal of cancer research and clinical oncology 131: 649-652.
    • (2005) Journal of Cancer Research and Clinical Oncology , vol.131 , pp. 649-652
    • Gwak, G.Y.1    Yoon, J.H.2    Shin, C.M.3    Ahn, Y.J.4    Chung, J.K.5
  • 45
    • 0037624602 scopus 로고    scopus 로고
    • Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma
    • Tannapfel A, Sommerer F, Benicke M, Katalinic A, Uhlmann D, et al. (2003) Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. Gut 52: 706-712.
    • (2003) Gut , vol.52 , pp. 706-712
    • Tannapfel, A.1    Sommerer, F.2    Benicke, M.3    Katalinic, A.4    Uhlmann, D.5
  • 49
    • 34247177532 scopus 로고    scopus 로고
    • Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma
    • Scheimann AO, Strautnieks SS, Knisely AS, Byrne JA, Thompson RJ, et al. (2007) Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma. The Journal of pediatrics 150: 556-559.
    • (2007) The Journal of Pediatrics , vol.150 , pp. 556-559
    • Scheimann, A.O.1    Strautnieks, S.S.2    Knisely, A.S.3    Byrne, J.A.4    Thompson, R.J.5
  • 50
  • 51
    • 0035093749 scopus 로고    scopus 로고
    • E-cadherin gene mutations in human intrahepatic cholangiocarcinoma
    • Endo K, Ashida K, Miyake N, Terada T, (2001) E-cadherin gene mutations in human intrahepatic cholangiocarcinoma. The Journal of pathology 193: 310-317.
    • (2001) The Journal of Pathology , vol.193 , pp. 310-317
    • Endo, K.1    Ashida, K.2    Miyake, N.3    Terada, T.4
  • 52
    • 0036623359 scopus 로고    scopus 로고
    • Gene amplification and mRNA and protein overexpression of c-erbB-2 (HER-2/neu) in human intrahepatic cholangiocarcinoma as detected by fluorescence in situ hybridization, in situ hybridization, and immunohistochemistry
    • Ukita Y, Kato M, Terada T, (2002) Gene amplification and mRNA and protein overexpression of c-erbB-2 (HER-2/neu) in human intrahepatic cholangiocarcinoma as detected by fluorescence in situ hybridization, in situ hybridization, and immunohistochemistry. Journal of hepatology 36: 780-785.
    • (2002) Journal of Hepatology , vol.36 , pp. 780-785
    • Ukita, Y.1    Kato, M.2    Terada, T.3
  • 53
    • 84896492774 scopus 로고    scopus 로고
    • FGFR2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma
    • doi:[], 10.1002/hep.26890. [Epub ahead of print]
    • Arai Y, Totoki Y, Hosoda F, Shirota T, Hama N, et al. (2013) FGFR2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. Hepatology 2013 Oct 9doi:[]10.1002/hep.26890. [Epub ahead of print].
    • (2013) Hepatology , vol.2013
    • Arai, Y.1    Totoki, Y.2    Hosoda, F.3    Shirota, T.4    Hama, N.5
  • 54
  • 55
    • 0035026704 scopus 로고    scopus 로고
    • Predicting deleterious amino acid substitutions
    • Ng PC, Henikoff S, (2001) Predicting deleterious amino acid substitutions. Genome Res 11: 863-874.
    • (2001) Genome Res , vol.11 , pp. 863-874
    • Ng, P.C.1    Henikoff, S.2
  • 57
    • 44949137643 scopus 로고    scopus 로고
    • Determinants of protein function revealed by combinatorial entropy optimization
    • Reva B, Antipin Y, Sander C, (2007) Determinants of protein function revealed by combinatorial entropy optimization. Genome Biol 8: R232.
    • (2007) Genome Biol , vol.8
    • Reva, B.1    Antipin, Y.2    Sander, C.3
  • 58
    • 77955151784 scopus 로고    scopus 로고
    • MutationTaster evaluates disease-causing potential of sequence alterations
    • Schwarz JM, Rodelsperger C, Schuelke M, Seelow D, (2010) MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 7: 575-576.
    • (2010) Nat Methods , vol.7 , pp. 575-576
    • Schwarz, J.M.1    Rodelsperger, C.2    Schuelke, M.3    Seelow, D.4
  • 59
    • 84872585155 scopus 로고    scopus 로고
    • Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities
    • Craig DW, O'Shaughnessy JA, Kiefer JA, Aldrich J, Sinari S, et al. (2013) Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities. Mol Cancer Ther 12: 104-116.
    • (2013) Mol Cancer Ther , vol.12 , pp. 104-116
    • Craig, D.W.1    O'Shaughnessy, J.A.2    Kiefer, J.A.3    Aldrich, J.4    Sinari, S.5
  • 61
    • 0037393850 scopus 로고    scopus 로고
    • A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2
    • Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, et al. (2003) A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 9: 407-415.
    • (2003) Nat Med , vol.9 , pp. 407-415
    • Qi, J.H.1    Ebrahem, Q.2    Moore, N.3    Murphy, G.4    Claesson-Welsh, L.5
  • 62
    • 84860807231 scopus 로고    scopus 로고
    • Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis
    • Salvucci O, Tosato G, (2012) Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis. Adv Cancer Res 114: 21-57.
    • (2012) Adv Cancer Res , vol.114 , pp. 21-57
    • Salvucci, O.1    Tosato, G.2
  • 63
    • 1042267263 scopus 로고    scopus 로고
    • Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
    • Cavallaro U, Christofori G, (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4: 118-132.
    • (2004) Nat Rev Cancer , vol.4 , pp. 118-132
    • Cavallaro, U.1    Christofori, G.2
  • 64
    • 84857692095 scopus 로고    scopus 로고
    • Two mutations in human BICC1 resulting in Wnt pathway hyperactivity associated with cystic renal dysplasia
    • Kraus MR, Clauin S, Pfister Y, Di Maio M, Ulinski T, et al. (2012) Two mutations in human BICC1 resulting in Wnt pathway hyperactivity associated with cystic renal dysplasia. Hum Mutat 33: 86-90.
    • (2012) Hum Mutat , vol.33 , pp. 86-90
    • Kraus, M.R.1    Clauin, S.2    Pfister, Y.3    Di Maio, M.4    Ulinski, T.5
  • 65
    • 77957829001 scopus 로고    scopus 로고
    • CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer
    • Wang X, Osada T, Wang Y, Yu L, Sakakura K, et al. (2010) CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer. J Natl Cancer Inst 102: 1496-1512.
    • (2010) J Natl Cancer Inst , vol.102 , pp. 1496-1512
    • Wang, X.1    Osada, T.2    Wang, Y.3    Yu, L.4    Sakakura, K.5
  • 67
    • 80051554317 scopus 로고    scopus 로고
    • Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor
    • Antonescu CR, Zhang L, Nielsen GP, Rosenberg AE, Dal Cin P, et al. (2011) Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor. Genes Chromosomes Cancer 50: 757-764.
    • (2011) Genes Chromosomes Cancer , vol.50 , pp. 757-764
    • Antonescu, C.R.1    Zhang, L.2    Nielsen, G.P.3    Rosenberg, A.E.4    Dal Cin, P.5
  • 68
    • 64549137103 scopus 로고    scopus 로고
    • Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions
    • Hallor KH, Sciot R, Staaf J, Heidenblad M, Rydholm A, et al. (2009) Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions. J Pathol 217: 716-727.
    • (2009) J Pathol , vol.217 , pp. 716-727
    • Hallor, K.H.1    Sciot, R.2    Staaf, J.3    Heidenblad, M.4    Rydholm, A.5
  • 69
    • 70449523183 scopus 로고    scopus 로고
    • Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
    • Kumar R, Crouthamel MC, Rominger DH, Gontarek RR, Tummino PJ, et al. (2009) Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors. Br J Cancer 101: 1717-1723.
    • (2009) Br J Cancer , vol.101 , pp. 1717-1723
    • Kumar, R.1    Crouthamel, M.C.2    Rominger, D.H.3    Gontarek, R.R.4    Tummino, P.J.5
  • 70
    • 84875273076 scopus 로고    scopus 로고
    • TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways
    • Ha GH, Park JS, Breuer EK, (2013) TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways. Cancer Lett 332: 63-73.
    • (2013) Cancer Lett , vol.332 , pp. 63-73
    • Ha, G.H.1    Park, J.S.2    Breuer, E.K.3
  • 71
    • 75149170979 scopus 로고    scopus 로고
    • Fibroblast growth factor signalling: from development to cancer
    • Turner N, Grose R, (2010) Fibroblast growth factor signalling: from development to cancer. Nature reviews Cancer 10: 116-129.
    • (2010) Nature Reviews Cancer , vol.10 , pp. 116-129
    • Turner, N.1    Grose, R.2
  • 72
    • 84873045850 scopus 로고    scopus 로고
    • Oncogenic FGFR3 gene fusions in bladder cancer. Human molecular genetics
    • Williams SV, Hurst CD, Knowles MA, (2012) Oncogenic FGFR3 gene fusions in bladder cancer. Human molecular genetics. Hum Mol Genet 22: 795-803.
    • (2012) Hum Mol Genet , vol.22 , pp. 795-803
    • Williams, S.V.1    Hurst, C.D.2    Knowles, M.A.3
  • 73
    • 14944369975 scopus 로고    scopus 로고
    • Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML
    • Maeda T, Yagasaki F, Ishikawa M, Takahashi N, Bessho M, (2005) Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML. Blood 105: 2115-2123.
    • (2005) Blood , vol.105 , pp. 2115-2123
    • Maeda, T.1    Yagasaki, F.2    Ishikawa, M.3    Takahashi, N.4    Bessho, M.5
  • 74
    • 82655179976 scopus 로고    scopus 로고
    • Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases
    • Ren M, Qin H, Ren R, Tidwell J, Cowell JK, (2011) Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases. Cancer research 71: 7312-7322.
    • (2011) Cancer Research , vol.71 , pp. 7312-7322
    • Ren, M.1    Qin, H.2    Ren, R.3    Tidwell, J.4    Cowell, J.K.5
  • 76
    • 0030842266 scopus 로고    scopus 로고
    • A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene
    • Richelda R, Ronchetti D, Baldini L, Cro L, Viggiano L, et al. (1997) A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene. Blood 90: 4062-4070.
    • (1997) Blood , vol.90 , pp. 4062-4070
    • Richelda, R.1    Ronchetti, D.2    Baldini, L.3    Cro, L.4    Viggiano, L.5
  • 77
    • 47949114797 scopus 로고    scopus 로고
    • Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders
    • Cross NC, Reiter A, (2008) Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders. Acta haematologica 119: 199-206.
    • (2008) Acta Haematologica , vol.119 , pp. 199-206
    • Cross, N.C.1    Reiter, A.2
  • 78
    • 84865805666 scopus 로고    scopus 로고
    • Transforming fusions of FGFR and TACC genes in human glioblastoma
    • Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, et al. (2012) Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 337: 1231-1235.
    • (2012) Science , vol.337 , pp. 1231-1235
    • Singh, D.1    Chan, J.M.2    Zoppoli, P.3    Niola, F.4    Sullivan, R.5
  • 79
    • 84879418850 scopus 로고    scopus 로고
    • Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas
    • Wang P, Dong Q, Zhang C, Kuan PF, Liu Y, et al. (2012) Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene 32: 3091-100.
    • (2012) Oncogene , vol.32 , pp. 3091-3100
    • Wang, P.1    Dong, Q.2    Zhang, C.3    Kuan, P.F.4    Liu, Y.5
  • 80
    • 69049097145 scopus 로고    scopus 로고
    • Bicaudal C, a novel regulator of Dvl signaling abutting RNA-processing bodies, controls cilia orientation and leftward flow
    • Maisonneuve C, Guilleret I, Vick P, Weber T, Andre P, et al. (2009) Bicaudal C, a novel regulator of Dvl signaling abutting RNA-processing bodies, controls cilia orientation and leftward flow. Development 136: 3019-3030.
    • (2009) Development , vol.136 , pp. 3019-3030
    • Maisonneuve, C.1    Guilleret, I.2    Vick, P.3    Weber, T.4    Andre, P.5
  • 81
    • 0344445675 scopus 로고    scopus 로고
    • A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning
    • Petiot A, Conti FJ, Grose R, Revest JM, Hodivala-Dilke KM, et al. (2003) A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning. Development 130: 5493-5501.
    • (2003) Development , vol.130 , pp. 5493-5501
    • Petiot, A.1    Conti, F.J.2    Grose, R.3    Revest, J.M.4    Hodivala-Dilke, K.M.5
  • 82
    • 0030665570 scopus 로고    scopus 로고
    • Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells
    • Feng S, Wang F, Matsubara A, Kan M, McKeehan WL, (1997) Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Cancer Res 57: 5369-5378.
    • (1997) Cancer Res , vol.57 , pp. 5369-5378
    • Feng, S.1    Wang, F.2    Matsubara, A.3    Kan, M.4    McKeehan, W.L.5
  • 83
    • 0033518110 scopus 로고    scopus 로고
    • Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer
    • Ricol D, Cappellen D, El Marjou A, Gil-Diez-de-Medina S, Girault JM, et al. (1999) Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer. Oncogene 18: 7234-7243.
    • (1999) Oncogene , vol.18 , pp. 7234-7243
    • Ricol, D.1    Cappellen, D.2    El Marjou, A.3    Gil-Diez-de-Medina, S.4    Girault, J.M.5
  • 84
    • 0030812901 scopus 로고    scopus 로고
    • Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations
    • Lorenzi MV, Castagnino P, Chen Q, Chedid M, Miki T, (1997) Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations. Oncogene 15: 817-826.
    • (1997) Oncogene , vol.15 , pp. 817-826
    • Lorenzi, M.V.1    Castagnino, P.2    Chen, Q.3    Chedid, M.4    Miki, T.5
  • 85
    • 36348943566 scopus 로고    scopus 로고
    • Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome
    • Chase A, Grand FH, Cross NC, (2007) Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome. Blood 110: 3729-3734.
    • (2007) Blood , vol.110 , pp. 3729-3734
    • Chase, A.1    Grand, F.H.2    Cross, N.C.3
  • 86
    • 84871491773 scopus 로고    scopus 로고
    • FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor
    • Guagnano V, Kauffmann A, Wohrle S, Stamm C, Ito M, et al. (2012) FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor. Cancer discovery 2: 1118-1133.
    • (2012) Cancer Discovery , vol.2 , pp. 1118-1133
    • Guagnano, V.1    Kauffmann, A.2    Wohrle, S.3    Stamm, C.4    Ito, M.5
  • 87
    • 84859402751 scopus 로고    scopus 로고
    • Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models
    • Gozgit JM, Wong MJ, Moran L, Wardwell S, Mohemmad QK, et al. (2012) Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models. Molecular cancer therapeutics 11: 690-699.
    • (2012) Molecular Cancer Therapeutics , vol.11 , pp. 690-699
    • Gozgit, J.M.1    Wong, M.J.2    Moran, L.3    Wardwell, S.4    Mohemmad, Q.K.5
  • 88
    • 78650231488 scopus 로고    scopus 로고
    • Significance of keratinocyte growth factor receptor in the proliferation of biliary tract cancer
    • Amano R, Yamada N, Doi Y, Yashiro M, Ohira M, et al. (2010) Significance of keratinocyte growth factor receptor in the proliferation of biliary tract cancer. Anticancer Res 30: 4115-4121.
    • (2010) Anticancer Res , vol.30 , pp. 4115-4121
    • Amano, R.1    Yamada, N.2    Doi, Y.3    Yashiro, M.4    Ohira, M.5
  • 89
    • 34447322566 scopus 로고    scopus 로고
    • Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
    • Kumar R, Knick VB, Rudolph SK, Johnson JH, Crosby RM, et al. (2007) Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity. Mol Cancer Ther 6: 2012-2021.
    • (2007) Mol Cancer Ther , vol.6 , pp. 2012-2021
    • Kumar, R.1    Knick, V.B.2    Rudolph, S.K.3    Johnson, J.H.4    Crosby, R.M.5
  • 90
    • 27544450547 scopus 로고    scopus 로고
    • Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype
    • Ballaro C, Ceccarelli S, Tiveron C, Tatangelo L, Salvatore AM, et al. (2005) Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype. EMBO reports 6: 755-761.
    • (2005) EMBO Reports , vol.6 , pp. 755-761
    • Ballaro, C.1    Ceccarelli, S.2    Tiveron, C.3    Tatangelo, L.4    Salvatore, A.M.5
  • 91
    • 33646588346 scopus 로고    scopus 로고
    • Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation
    • Ferby I, Reschke M, Kudlacek O, Knyazev P, Pante G, et al. (2006) Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation. Nature medicine 12: 568-573.
    • (2006) Nature Medicine , vol.12 , pp. 568-573
    • Ferby, I.1    Reschke, M.2    Kudlacek, O.3    Knyazev, P.4    Pante, G.5
  • 93
    • 79952297518 scopus 로고    scopus 로고
    • Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer
    • Lin CI, Du J, Shen WT, Whang EE, Donner DB, et al. (2011) Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer. The Journal of clinical endocrinology and metabolism 96: E554-565.
    • (2011) The Journal of Clinical Endocrinology and Metabolism , vol.96
    • Lin, C.I.1    Du, J.2    Shen, W.T.3    Whang, E.E.4    Donner, D.B.5
  • 94
    • 77950602115 scopus 로고    scopus 로고
    • Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma
    • Reschke M, Ferby I, Stepniak E, Seitzer N, Horst D, et al. (2010) Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma. Hepatology 51: 1383-1390.
    • (2010) Hepatology , vol.51 , pp. 1383-1390
    • Reschke, M.1    Ferby, I.2    Stepniak, E.3    Seitzer, N.4    Horst, D.5
  • 95
    • 0038037236 scopus 로고    scopus 로고
    • Feedback inhibition by RALT controls signal output by the ErbB network
    • Anastasi S, Fiorentino L, Fiorini M, Fraioli R, Sala G, et al. (2003) Feedback inhibition by RALT controls signal output by the ErbB network. Oncogene 22: 4221-4234.
    • (2003) Oncogene , vol.22 , pp. 4221-4234
    • Anastasi, S.1    Fiorentino, L.2    Fiorini, M.3    Fraioli, R.4    Sala, G.5
  • 96
    • 36749011864 scopus 로고    scopus 로고
    • Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface
    • Zhang X, Pickin KA, Bose R, Jura N, Cole PA, et al. (2007) Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 450: 741-744.
    • (2007) Nature , vol.450 , pp. 741-744
    • Zhang, X.1    Pickin, K.A.2    Bose, R.3    Jura, N.4    Cole, P.A.5
  • 97
    • 77951785332 scopus 로고    scopus 로고
    • A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation
    • Frosi Y, Anastasi S, Ballaro C, Varsano G, Castellani L, et al. (2010) A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation. The Journal of cell biology 189: 557-571.
    • (2010) The Journal of Cell Biology , vol.189 , pp. 557-571
    • Frosi, Y.1    Anastasi, S.2    Ballaro, C.3    Varsano, G.4    Castellani, L.5
  • 98
    • 22744445536 scopus 로고    scopus 로고
    • Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin
    • Anastasi S, Sala G, Huiping C, Caprini E, Russo G, et al. (2005) Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin. Oncogene 24: 4540-4548.
    • (2005) Oncogene , vol.24 , pp. 4540-4548
    • Anastasi, S.1    Sala, G.2    Huiping, C.3    Caprini, E.4    Russo, G.5
  • 99
    • 78649823233 scopus 로고    scopus 로고
    • Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes
    • Duncan CG, Killela PJ, Payne CA, Lampson B, Chen WC, et al. (2010) Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes. Oncotarget 1: 265-277.
    • (2010) Oncotarget , vol.1 , pp. 265-277
    • Duncan, C.G.1    Killela, P.J.2    Payne, C.A.3    Lampson, B.4    Chen, W.C.5
  • 101
    • 84861863346 scopus 로고    scopus 로고
    • Downregulation of Mig-6 in nonsmall-cell lung cancer is associated with EGFR signaling
    • Li Z, Dong Q, Wang Y, Qu L, Qiu X, et al. (2012) Downregulation of Mig-6 in nonsmall-cell lung cancer is associated with EGFR signaling. Molecular carcinogenesis 51: 522-534.
    • (2012) Molecular Carcinogenesis , vol.51 , pp. 522-534
    • Li, Z.1    Dong, Q.2    Wang, Y.3    Qu, L.4    Qiu, X.5
  • 102
    • 84862216069 scopus 로고    scopus 로고
    • Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation
    • Zhang YW, Staal B, Dykema KJ, Furge KA, Vande Woude GF, (2012) Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation. PloS one 7: e38955.
    • (2012) PloS One , vol.7
    • Zhang, Y.W.1    Staal, B.2    Dykema, K.J.3    Furge, K.A.4    Vande Woude, G.F.5
  • 103
    • 33846215432 scopus 로고    scopus 로고
    • Evidence that MIG-6 is a tumor-suppressor gene
    • Zhang YW, Staal B, Su Y, Swiatek P, Zhao P, et al. (2007) Evidence that MIG-6 is a tumor-suppressor gene. Oncogene 26: 269-276.
    • (2007) Oncogene , vol.26 , pp. 269-276
    • Zhang, Y.W.1    Staal, B.2    Su, Y.3    Swiatek, P.4    Zhao, P.5
  • 104
    • 77957331045 scopus 로고    scopus 로고
    • GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling
    • Bai A, Meetze K, Vo NY, Kollipara S, Mazsa EK, et al. (2010) GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling. Cancer Res 70: 7630-7639.
    • (2010) Cancer Res , vol.70 , pp. 7630-7639
    • Bai, A.1    Meetze, K.2    Vo, N.Y.3    Kollipara, S.4    Mazsa, E.K.5
  • 105
    • 84876963318 scopus 로고    scopus 로고
    • Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs
    • Christoforides A, Carpten JD, Weiss GJ, Demeure MJ, Von Hoff DD, et al. (2013) Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs. BMC Genomics 14: 302.
    • (2013) BMC Genomics , vol.14 , pp. 302
    • Christoforides, A.1    Carpten, J.D.2    Weiss, G.J.3    Demeure, M.J.4    Von Hoff, D.D.5
  • 106
    • 80051507403 scopus 로고    scopus 로고
    • TopHat-Fusion: an algorithm for discovery of novel fusion transcripts
    • Kim D, Salzberg SL, (2011) TopHat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biol 12: R72.
    • (2011) Genome Biol , vol.12
    • Kim, D.1    Salzberg, S.L.2
  • 107
    • 80054003528 scopus 로고    scopus 로고
    • ChimeraScan: a tool for identifying chimeric transcription in sequencing data
    • Iyer MK, Chinnaiyan AM, Maher CA, (2011) ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics 27: 2903-2904.
    • (2011) Bioinformatics , vol.27 , pp. 2903-2904
    • Iyer, M.K.1    Chinnaiyan, A.M.2    Maher, C.A.3
  • 109
    • 80055071248 scopus 로고    scopus 로고
    • A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines
    • Asmann YW, Hossain A, Necela BM, Middha S, Kalari KR, et al. (2011) A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines. Nucleic Acids Res 39: e100.
    • (2011) Nucleic Acids Res , vol.39
    • Asmann, Y.W.1    Hossain, A.2    Necela, B.M.3    Middha, S.4    Kalari, K.R.5
  • 110
    • 84857769158 scopus 로고    scopus 로고
    • Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells
    • Diep CH, Zucker KM, Hostetter G, Watanabe A, Hu C, et al. (2012) Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells. PLoS One 7: e32783.
    • (2012) PLoS One , vol.7
    • Diep, C.H.1    Zucker, K.M.2    Hostetter, G.3    Watanabe, A.4    Hu, C.5
  • 112
    • 84869091997 scopus 로고    scopus 로고
    • Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
    • Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, et al. (2012) Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491: 399-405.
    • (2012) Nature , vol.491 , pp. 399-405
    • Biankin, A.V.1    Waddell, N.2    Kassahn, K.S.3    Gingras, M.C.4    Muthuswamy, L.B.5
  • 113
    • 84861625981 scopus 로고    scopus 로고
    • Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
    • Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, et al. (2012) Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nature genetics 44: 694-698.
    • (2012) Nature Genetics , vol.44 , pp. 694-698
    • Guichard, C.1    Amaddeo, G.2    Imbeaud, S.3    Ladeiro, Y.4    Pelletier, L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.